Luellmann
Table of contents :
1.pdf……Page 1
2.pdf……Page 2
tlink1……Page 7
References……Page 9
Alzheimer’s disease……Page 10
Neurotransmitters and memory……Page 11
Mild cognitive impairment……Page 13
Dementia……Page 15
Vascular dementia……Page 18
Dementia with Lewy bodies……Page 19
Prion disease……Page 20
Summary……Page 21
References……Page 22
Monamine oxidase inhibitors……Page 29
Major depressive disorders……Page 30
Pharmacotherapy……Page 32
Tricyclic antidepressants……Page 33
Atypical antipsychotics……Page 34
Psychotherapy……Page 37
Systems (family) therapy……Page 38
Electroconvulsive therapy……Page 39
Vagus nerve stimulation……Page 41
Deep brain stimulation……Page 42
References……Page 43
Falls and Their Prevention in Elderly People: What Does the Evidence Show?……Page 46
Epidemiology……Page 47
Causes and risk factors……Page 48
Multidimensional fall risk assessment and risk reduction……Page 53
Exercise interventions……Page 54
Environmental assessment and modification……Page 55
Institutional interventions……Page 56
Effectiveness of fall prevention strategies……Page 57
References……Page 59
Pathophysiology of urinary incontinence in older adults……Page 64
Mechanistic classification of urinary incontinence……Page 65
Clinical assessment of the older adult who has urinary incontinence……Page 67
Practical management strategies……Page 68
Nonpharmacologic treatment……Page 69
Pharmacologic therapy……Page 70
Invasive procedures and surgical management……Page 71
References……Page 72
Introduction……Page 76
Sarcopenia: a central factor in the pathophysiology of frailty……Page 77
Disease and frailty……Page 81
References……Page 82
Coronary artery disease……Page 87
Hypertensive heart disease……Page 90
Valvular aortic stenosis……Page 91
Aortic regurgitation……Page 92
Mitral regurgitation……Page 93
Congestive heart failure……Page 94
Atrial fibrillation……Page 95
Summary……Page 96
References……Page 97
Systolic heart failure……Page 101
Diagnosis……Page 103
Etiology and precipitating factors……Page 105
Etiology and precipitating factors……Page 107
Angiotensin receptor blockers……Page 109
beta-Blockers……Page 110
Aldosterone antagonists……Page 111
Diastolic heart failure……Page 112
Cardiac pacemakers……Page 113
Implantable cardioverter defibrillators……Page 114
Exercise……Page 115
End of life……Page 116
Future directions……Page 117
References……Page 118
The physiologic anorexia of aging……Page 124
Prevalence……Page 125
Weight loss in older people……Page 126
Causes of undernutrition in older people……Page 127
Diagnosis……Page 129
Management……Page 131
Morbidity……Page 132
Should overweight older people be advised to lose weight?……Page 133
Weight loss measures in overweight older people……Page 134
Vitamin D……Page 135
Calcium……Page 136
Clinical effects of B12 deficiency in older people……Page 137
Folate deficiency……Page 138
References……Page 139
Pathogenesis of type 2 diabetes in the elderly……Page 145
Complications……Page 149
Cognitive function……Page 150
Diagnosis and monitoring……Page 151
Postprandial hyperglycemia……Page 152
Therapeutic options……Page 153
Metformin……Page 154
Insulin……Page 155
References……Page 156
Immobility……Page 160
Phases of wound healing……Page 161
Intrinsic factors……Page 162
Comorbidities……Page 164
Aging skin……Page 165
Moisture……Page 166
Risk assessment……Page 167
Assessment of pressure ulcers……Page 169
Pressure relief……Page 172
Debridement……Page 173
Topical dressings……Page 174
References……Page 175
Introduction……Page 180
Definitions relating to seizures……Page 181
Definitions relating to elderly……Page 182
Cause……Page 186
Clinical presentation……Page 187
Status epilepticus……Page 189
Neuroimaging……Page 190
Inpatient electroencephalogram video monitoring……Page 191
Prognosis……Page 192
Medication treatment responsiveness, sensitivity, and adverse effects……Page 193
Future directions……Page 198
References……Page 200
Principles of aging in the care of older adult patients who have cancer……Page 202
Heterogeneity in aging……Page 203
Alterations in pharmacokinetics and pharmacodynamics of antineoplastic therapy……Page 204
Aging biology in the development of cancer……Page 205
Comprehensive geriatric assessment for patients who have cancer……Page 206
Cancer-specific treatment……Page 210
Symptom-specific treatment……Page 212
Supportive care……Page 213
The emergence of geriatric oncology……Page 214
References……Page 215
Palliative Care and Pain Management……Page 218
Communication……Page 219
Pain management……Page 222
Dyspnea……Page 229
Nausea……Page 231
Palliative care……Page 232
Hospice……Page 233
Psychosocial and spiritual realms……Page 234
Grief and bereavement……Page 235
References……Page 236
Epidemiology……Page 240
Biochemical determination of testosterone……Page 241
Testosterone and sexuality……Page 242
Erectile dysfunction and lower urinary tract symptoms……Page 243
Biochemistry……Page 244
Epidemiology……Page 245
Biochemistry……Page 246
Testosterone and bone……Page 247
Testosterone and health-related quality of life……Page 248
Testosterone treatments……Page 249
References……Page 251
Sexual changes that occur with aging……Page 259
Sexual myths of aging……Page 261
Erectile dysfunction……Page 262
Menopause……Page 264
Sexually transmitted diseases in the aging population……Page 265
Comorbidities affecting sexuality……Page 267
Religious and cultural aspects of sexuality……Page 268
References……Page 269
19.pdf……Page 271
Reviews
There are no reviews yet.